col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


15 Results       Page 1

 [1] 
Springer-Verlag: American Journal of Cardiovascular Drugs
  original article Date Title Authors   All Authors
1 [GO] 2024―Aug―13 COVID-19 Diagnosis, Oral Anticoagulation, and Stroke Risk in Patients with Atrial Fibrillation Lanting Yang, Shangbin Tang, Jingchuan Guo, Nico Gabriel, Walid F. Gellad, Utibe R. Essien, et al. (+2)
2 [GO] 2022―Aug―25 Remdesivir-induced Bradycardia is not Associated with Worse Outcome in Patients with COVID-19: A Retrospective Analysis Ioannis Pantazopoulos, Georgios Mavrovounis, Georgios Dimeas, Nikolaos Zikos, Maria Pitsikou, Eleni Rousogianni, et al. (+9)
3 [GO] 2021―Dec―21 Correction to: Proposed Pathogenesis, Characteristics, and Management of COVID-19 mRNA Vaccine-Related Myopericarditis Adrija Hajra, Manasvi Gupta, Binita Ghosh, Kumar Ashish, Neelkumar Patel, Gaurav Manek, et al. (+5)
4 [GO] 2021―Nov―24 Proposed Pathogenesis, Characteristics, and Management of COVID-19 mRNA Vaccine-Related Myopericarditis Adrija Hajra, Manasvi Gupta, Binita Ghosh, Kumar Ashish, Neelkumar Patel, Gaurav Manek, et al. (+3)
5 [GO] 2021―Aug―03 The Association Between the Use of Statins and Clinical Outcomes in Patients with COVID-19: A Systematic Review and Meta-analysis Chia Siang Kow, Syed Shahzad Hasan
6 [GO] 2021―Mar―26 Impact of the COVID-19 Pandemic on Global Anticoagulant Sales: A Cross-Sectional Analysis Across 39 Countries Inmaculada Hernandez, Mina Tadrous, Jared W. Magnani, Jingchuan Guo, Katie J. Suda
7 [GO] 2021―Mar―22 Treating Acute Decompensated Heart Failure in Patients with COVID-19 Using Intravenous Nitroglycerin in 5% Glutathione Wayne Kaesemeyer, Tatsiana Suvorava
8 [GO] 2020―Nov―03 Questions and Answers on Practical Thrombotic Issues in SARS-CoV-2 Infection: A Guidance Document from the Italian Working Group on Atherosclerosis, Thrombosis and Vascular Biology Giuseppe Patti, Veronica Lio, Ilaria Cavallari, Felice Gragnano, Letizia Riva, Paolo Calabrò, et al. (+3)
9 [GO] 2020―Sep―12 Mortality and Disease Severity Among COVID-19 Patients Receiving Renin-Angiotensin System Inhibitors: A Systematic Review and Meta-analysis Syed Shahzad Hasan, Chia Siang Kow, Muhammad Abdul Hadi, Syed Tabish Razi Zaidi, Hamid A. Merchant
10 [GO] 2020―Sep―12 Potential Therapeutic Roles for Direct Factor Xa Inhibitors in Coronavirus Infections Rami A. Al-Horani
11 [GO] 2020―Aug―04 Current Overview on Hypercoagulability in COVID-19 Namrata Singhania, Saurabh Bansal, Divya P. Nimmatoori, Abutaleb A. Ejaz, Peter A. McCullough, Girish Singhania
12 [GO] 2020―Aug―01 Amiodarone in the COVID-19 Era: Treatment for Symptomatic Patients Only, or Drug to Prevent Infection? Fabian Sanchis-Gomar, Carl J. Lavie, Daniel P. Morin, Carme Perez-Quilis, Jari A. Laukkanen, Marco V. Perez
13 [GO] 2020―Jun―23 COVID-19 Pandemic: Cardiovascular Complications and Future Implications Dhrubajyoti Bandyopadhyay, Tauseef Akhtar, Adrija Hajra, Manasvi Gupta, Avash Das, Sandipan Chakraborty, et al. (+7)
14 [GO] 2020―May―26 Management of Outpatient Warfarin Therapy amid COVID-19 Pandemic: A Practical Guide Chia Siang Kow, Wendy Sunter, Amie Bain, Syed Tabish Razi Zaidi, Syed Shahzad Hasan
15 [GO] 2020―Apr―13 Cardiovascular Disease and Use of Renin-Angiotensin System Inhibitors in COVID-19 Chia Siang Kow, Syed Tabish Razi Zaidi, Syed Shahzad Hasan
 [1] 

15 Results       Page 1



[de][en]

Last change 2025―Jul―29 14:55:09 UTC

© Daten-Quadrat 2022       Done in 0.024 sec